HCA Florida Northwest Hospital acquired Anovo for use in transvaginal benign gynecological procedures including hysterectomies.
The system represents the first and only FDA-authorized surgical robot with shoulder, elbow and wrist joints, Momentis said. Momentis — formerly Memic Innovative Surgery — designed Anovo (formerly Hominis) to mimic human arms. This allows it to provide human-level dexterity, the company said. (Read about 16 surgical robotics companies you need to know.)
“It is essential for surgeons to use the most advanced tools and technologies to ensure we deliver optimal care to our patients, and this system presents several advantages compared to other available robotic technologies,” said Dr. Daniel Gomez, a minimally invasive gynecologic surgeon and assistant program director of the OBGYN Residency Program at HCA Florida Northwest Hospital. “By enabling the transvaginal approach to benign gynecological procedures including benign hysterectomies, we can perform minimally invasive surgery that may deliver benefits including less pain after surgery, leading to a faster recovery, and virtually no visible scarring.
“We are also excited to train the next generation of gynecologic surgeons on this new platform to further advance the surgical care that our current OBGYN residents will provide to their patients in the future.”
About Anovo from Momentis Surgical
Anovo received FDA de novo marketing authorization in February 2021. This authorization covered use in single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures. These include benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal.
The system allows for multiple instruments introduced to the body through a single portal. The articulation offers optimal access and working angles. Momentis said Anovo’s transvaginal approach enables benefits such as less patient pain. It also leads to less scarring, shorter recovery times and reduced infection rates.
Anovo also requires a smaller footprint and costs less than conventional robotic surgery systems, the company said.
“We are pleased to have growing support from leading medical facilities in Florida including HCA Florida Northwest Hospital and hope to continue our momentum as we work to build broader commercial adoption of the Anovo System,” said Dvir Cohen, CEO and co-founder of Momentis.